Verdad Advisers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$453K Buy
+1,165
New +$465K 0.49% 75
2026
Q2
– Sell
-709
Closed -$208K – 236
2026
Q1
$208K Buy
+709
New +$233K 0.23% 130
2024
Q3
$1.63M Buy
3,134
+119
+4% +$63.6K 2.18% 8
2024
Q2
$1.63M Buy
3,015
+865
+40% +$457K 1.89% 8
2024
Q1
$1.11M Buy
+2,150
New +$1.07M 1.21% 19

Other funds holding ELV

Verdad Advisers's ELV Position: Q3 2026 in Review

Verdad Advisers opened a new position in Elevance Health (ELV) in Q3 2026: 1,165 shares worth $453K. The stake represents 0.49% of the portfolio and ranks #75 among its holdings. This is a return to the name: Verdad Advisers previously reported a position in ELV as recently as Q1 2026.

Verdad Advisers first reported a position in ELV in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.63M in Q2 2024. 1,616 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Verdad Advisers held 1,165 shares of Elevance Health worth $453K as of Q3 2026.
  • Elevance Health was a new Verdad Advisers position in Q3 2026.
  • Elevance Health made up 0.49% of Verdad Advisers's portfolio in Q3 2026, its #75 holding.
  • Verdad Advisers first reported a position in Elevance Health in Q1 2024 and has held it in 5 quarters since.
  • Verdad Advisers's Elevance Health position peaked at $1.63M in Q2 2024.
  • 1,616 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Verdad Advisers's 13F filing for Q3 2026, filed 16 Nov 2026.